STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,663,336 | -62.9% | 3,721,659 | 0.0% | 1.03% | -68.7% |
| Q2 2023 | $39,561,235 | +44.8% | 3,721,659 | +13.5% | 3.28% | +2.2% |
| Q1 2023 | $27,315,252 | +295.6% | 3,279,142 | +338.3% | 3.21% | +344.3% |
| Q4 2022 | $6,904,750 | -30.1% | 748,077 | -2.7% | 0.72% | -23.6% |
| Q3 2022 | $9,876,000 | -50.5% | 769,169 | -49.0% | 0.94% | -50.9% |
| Q2 2022 | $19,942,000 | -33.3% | 1,509,620 | +6.3% | 1.93% | -33.1% |
| Q1 2022 | $29,902,000 | +337.5% | 1,420,530 | +380.8% | 2.88% | +364.2% |
| Q4 2021 | $6,835,000 | +648.6% | 295,425 | +722.9% | 0.62% | +1341.9% |
| Q3 2021 | $913,000 | – | 35,899 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |